Pasithea Therapeutics (KTTA) Cash from Financing Activities (2021 - 2024)
Historic Cash from Financing Activities for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2024 value amounting to -$23550.0.
- Pasithea Therapeutics' Cash from Financing Activities changed N/A to -$23550.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$4.0 million, marking a year-over-year decrease of 771.93%. This contributed to the annual value of $4.5 million for FY2024, which is 22123.27% up from last year.
- According to the latest figures from Q4 2024, Pasithea Therapeutics' Cash from Financing Activities is -$23550.0.
- Over the past 5 years, Pasithea Therapeutics' Cash from Financing Activities peaked at $34.2 million during Q4 2021, and registered a low of -$3.9 million during Q3 2023.
- In the last 3 years, Pasithea Therapeutics' Cash from Financing Activities had a median value of $264103.0 in 2023 and averaged $7.5 million.